The Prognostic Implications of Microscopic Satellites in Patients with Clinical Stage I Melanoma

Archives of Surgery

Volumn 126, Issue 12, 1991, Pages 1461-1468

  León, Pablo ^a   Daly, John M ^a   Synnestvedt, Marie ^a   Schultz, Delray J ^a   Elder, David E ^a   Clark, Wallace H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MELANOMA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

COHORT STUDIES; FEMALE; HUMAN; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0026318663     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1991.01410360031006     Document Type: Article

References (34)

1. Lee YTM. Loco-regional primary and recurrent melanoma, III: update of natural history and non-systemic treatments (1980-1987). Cancer Treat Rev. 1988;15:135–162.
2. Mastrangelo MJ, Baker AR, Katz HR. Cutaneous melanoma. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 2nd ed. Philadelphia, Pa: JB Lippincott; 1990:1371–1422.
3. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biological behavior of primary human malignant melanoma of the skin. Cancer Res. 1969;29:705–726.
4. Breslow A. Thickness, cross-sectional areas and depth of invasion on the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902–908.
5. Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg. 1975;182:572–575.
6. Day CL, Mihm MC Jr, Lew RA, Kopf AW, Sober AJ, Fitzpatrick TB. Cutaneous malignant melanoma: prognostic guidelines for physicians and patients. CA. 1982;32:113–122.
7. Balch CM, Soong SW, Shaw HM, Milton GW. An analysis of prognostic factors in 4000 patients with cutaneous melanoma. In: Balch CM, Milton GW, eds. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. Philadelphia, Pa: JB Lippincott; 1985:321–352.
8. Cascinelli N, Marubini E, Bufalino R. Prognostic factors for stage I melanoma of the skin: a review. Stat Med. 1985;4:265–278.
9. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.00 mm thick) skin melanoma. Am J Pathol. 1988;133:419–423.
10. Clark WH Jr, Elder DE, Van Horn M. The biological forms of malignant melanoma. Hum Pathol. 1986;17:443–450.
11. Clark WH Jr, Elder DE, Guerry D IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81:1893–1904.
12. Elder DE, Lusk E, Guerry D IV, et al. Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol. 1984;6(suppl 1):55–61.
13. Vollmer RT. Malignant melanoma: a multivariate analysis of prognostic factors. Pathol Annu. 1989;24:383–407.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.
15. Cox DR. Regression model and life tables. J R Stat Soc Br. 1972;34:187–220.
16. Day CL, Harrist TJ, Gorstein F, et al. Malignant melanoma: prognostic significance of ‘microscopic satellites’ in the reticular dermis and subcutaneous fat. Ann Surg. 1981;194:108–112.
17. Day CL Jr, Mihm MC Jr, Lew RA, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm): a conceptual model for tumor growth and metastasis. Ann Surg. 1982;195:35–43.
18. Harrist TJ, Rigel DS, Day CL, et al. ‘Microscopic satellites’ are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer. 1984;53:2183–2187.
19. Urist MM. Balch CM, Soong SJ, Shaw HM, Milton GW, Maddox WA. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer. 1985;55:1398–1402.
20. Brogelli L, Carli P, Reali UM, Pimpinelli N, Moretti S. Antigenic phenotype of radial growth phase with or without a vertical growth phase portion. Tumori. 1988;74:157–162.
21. Elder DE, Rodeck U, Thurin J, et al. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res. 1989;49:5091–5096.
22. Herlyn M, Clark WH Jr, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest. 1987;56:461–474.
23. Cascinelli N, Morabito A, Bufalino R, et al. Prognosis of stage I melanoma of the skin. Int J Cancer. 1980;26:733–739.
24. Cox EB. Prognostic factors in malignant melanoma. In: Siegler HF, ed. Clinical Management of Melanoma. Hingham, Mass: Martinus Nijhoff Publishers; 1982:279.
25. Day CL Jr, Sober AJ, Kopf AW, et al. A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease. Surgery. 1981;89:599–603.
26. Day CL Jr, Sober AJ, Kopf AW, et al. A prognostic model for clinical stage I melanoma of the trunk: location near the midline is not an independent risk factor for recurrent disease. Am J Surg. 1981;142:247–251.
27. Day CL Jr, Sober AJ, Kopf AW, et al. A prognostic model for clinical stage I melanoma of the upper extremity: the importance of anatomic subsites in predicting recurrent disease. Ann Surg. 1981;193:436–440.
28. Eldh J, Boeryd B, Peterson LE. Prognostic factors in cutaneous malignant melanoma in stage I: a clinical morphological and multivariate analysis. Scand J Plast Reconstr Surg Hand Surg. 1978;12:243.
29. Hacene K, Le Doussal V, Brunet M, Lemoine F, Guerin P, Herbert H. Prognostic index for clinical stage I cutaneous melanoma. Cancer Res. 1983;43:2991–2996.
30. Prade M, Bognel C, Charpentier P, et al. Malignant melanoma of the skin: prognostic factors derived from a multifactorial analysis of 239 cases. Am J Dermatopathol. 1982;4:411.
31. Schmoeckel C, Bockelbrink A, Bockelbrink H, BraunFalco O. Low and high risk malignant melanoma, II: multivariate analyses for a prognostic classification. Eur J Cancer. 1983;19:237–243.
32. Schmoeckel C, Bockelbrink A, Bockelbrink H, Koutsis J, Braun-Falco O. Low and high risk malignant melanoma, I: evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer. 1983;19:227–235.
33. Van Der Esch EP, Cascinelli N, Morabito A, Bufalino R. Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristics. Cancer. 1981;48:1668.
34. Drzewiecki KT, Anderson PK. Survival with malignant melanoma: a regression analysis of prognostic factors. Cancer. 1982;49:214.